DK2046802T3 - 2-substituerede methylpenamderivater - Google Patents

2-substituerede methylpenamderivater

Info

Publication number
DK2046802T3
DK2046802T3 DK07804590.3T DK07804590T DK2046802T3 DK 2046802 T3 DK2046802 T3 DK 2046802T3 DK 07804590 T DK07804590 T DK 07804590T DK 2046802 T3 DK2046802 T3 DK 2046802T3
Authority
DK
Denmark
Prior art keywords
methylpenam
derivatives
substituted
substituted methylpenam
methylpenam derivatives
Prior art date
Application number
DK07804590.3T
Other languages
English (en)
Inventor
Palanisamy Senthilkumar Udayampalayam
Andrew Gnanaprakasam
Panchapakesan Ganapathy
Gohain Mukut
Hariharan Venkatasubramanian
Rajagopal Sriram
Maneesh Paul-Satyaseela
Shakti Singh Solanki
Sathishkumar Devarajan
Original Assignee
Allecra Therapeutics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allecra Therapeutics Gmbh filed Critical Allecra Therapeutics Gmbh
Application granted granted Critical
Publication of DK2046802T3 publication Critical patent/DK2046802T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/86Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK07804590.3T 2006-07-12 2007-07-11 2-substituerede methylpenamderivater DK2046802T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1217CH2006 2006-07-12
PCT/IB2007/001941 WO2008010048A2 (en) 2006-07-12 2007-07-11 Novel 2-substituted methyl penam derivatives

Publications (1)

Publication Number Publication Date
DK2046802T3 true DK2046802T3 (da) 2013-09-16

Family

ID=38949982

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07804590.3T DK2046802T3 (da) 2006-07-12 2007-07-11 2-substituerede methylpenamderivater

Country Status (9)

Country Link
US (1) US7687488B2 (da)
EP (1) EP2046802B1 (da)
CY (1) CY1114927T1 (da)
DK (1) DK2046802T3 (da)
ES (1) ES2427122T3 (da)
PL (1) PL2046802T3 (da)
PT (1) PT2046802E (da)
SI (1) SI2046802T1 (da)
WO (1) WO2008010048A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101735987B (zh) * 2008-11-04 2011-07-13 中华人民共和国北京出入境检验检疫局 抗阿莫西林和氨苄西林小鼠单克隆抗体细胞株
KR101302564B1 (ko) * 2009-10-28 2013-09-02 한국전자통신연구원 비아 형성 방법 및 이를 이용하는 적층 칩 패키지의 제조 방법
KR101933084B1 (ko) * 2010-11-25 2018-12-28 알레크라 테라퓨틱스 게엠베하 화합물 및 그의 용도
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
GB201319776D0 (en) * 2013-11-08 2013-12-25 Allecra Therapeutics Sas Compound
GB201408649D0 (en) * 2014-05-15 2014-07-02 Allecra Therapeutics Sas Method
CN106483231A (zh) * 2016-10-09 2017-03-08 江西出入境检验检疫局检验检疫综合技术中心 一种丙二醇脂肪酸酯中总单酯及游离丙二醇含量的测定方法
EP3372587A1 (en) 2017-03-09 2018-09-12 Centre National de la Recherche Scientifique (CNRS) 3-imidazolines as carbapenemases inhibitors
CN115197244B (zh) * 2022-09-03 2023-07-07 石家庄学院 [1,2,4]三嗪并[3,2-b][1,3,5]噻二嗪类衍生物及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU541028B2 (en) * 1982-06-21 1984-12-13 Taiho Pharmaceutical Co., Ltd. 6-unsubstituted penicillin derivatives
US4562073A (en) 1982-12-24 1985-12-31 Taiho Pharmaceutical Company Limited Penicillin derivatives
JPS60215688A (ja) * 1984-04-09 1985-10-29 Taiho Yakuhin Kogyo Kk ペニシリン誘導体
IL92139A0 (en) * 1988-10-31 1990-07-12 Hoffmann La Roche Penicillanic acid derivatives,their manufacture and pharmaceutical compositions containing them
JP3866298B2 (ja) * 1997-12-29 2007-01-10 リサーチ コーポレイション テクノロジーズ,インコーポレイティド β−ラクタマーゼインヒビターとしての2β−置換化−6−アルキリデンペニシラン酸誘導体
US7273935B2 (en) * 2003-08-21 2007-09-25 Orchid Chemicals & Pharmaceuticals, Ltd. Process for the preparation of 3-methylcepham derivatives
US7417143B2 (en) * 2004-04-07 2008-08-26 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of Tazobactam in pure form

Also Published As

Publication number Publication date
US20080015156A1 (en) 2008-01-17
PL2046802T3 (pl) 2014-01-31
EP2046802A4 (en) 2010-06-02
US20090093423A2 (en) 2009-04-09
PT2046802E (pt) 2013-09-12
WO2008010048A2 (en) 2008-01-24
EP2046802B1 (en) 2013-08-21
WO2008010048A3 (en) 2008-04-03
CY1114927T1 (el) 2016-12-14
EP2046802A2 (en) 2009-04-15
SI2046802T1 (sl) 2014-03-31
US7687488B2 (en) 2010-03-30
ES2427122T3 (es) 2013-10-28

Similar Documents

Publication Publication Date Title
DK2016080T3 (da) Dihydropyrazolopyrimidinon-derivater
ATE483711T1 (de) Spiroindolinonderivate
ATE469905T1 (de) Pyridopyrimidinonderivate
ATE512135T1 (de) Spiroindolinonderivate
DK2035394T3 (da) 2-pyrazincarboxamidderivater
DK2164844T3 (da) Pyrimidinyl-pyridazinonderivater
DK2209786T3 (da) Pyrimidinsubstituerede purinderivater
BRPI0820112A2 (pt) Derivados de isoxazol-piridina
BRPI0809992A2 (pt) Derivados de pirrolopirimidina
BRPI0820113A2 (pt) Derivados de isoxazolo-piridazina
BRPI0813836A2 (pt) Derivados pirazólicos
BRPI0817935A2 (pt) Derivados de biarila
BRPI0812155A2 (pt) derivados de espiroindolinona
DK2046802T3 (da) 2-substituerede methylpenamderivater
ATE518837T1 (de) Indazolamidderivate
BRPI0814236A2 (pt) Derivados de quinazolinamida
BRPI0820649A2 (pt) Derivados de isoxazalo-pirazina
DK2134708T3 (da) 3-Cyano-4-(4-tetrahydropyranphenyl)-pyridin-2-on-derivater
BRPI0812247A2 (pt) Derivados de piridazinona
DK2152370T3 (da) Aryletherpyridazinonderivater
BRPI0821743A2 (pt) derivados de piridazinona
ATE544764T1 (de) 5-hydroxymethyloxazolidin-2-onderivate
BRPI0817579A2 (pt) Derivados de tiazol
DK2190837T3 (da) 4-pyrimidinsulfamid-derivat
FR2902426B1 (fr) Derives de cinnamoyl-piperazine